MEDICA is undoubtably the most important medical fair around the world, with 50 years of history and biggest influence in medical industry.
2018 is Singclean's 7th time attending Medica and is a mile stone of Singclean as well.
During the exhibition between 12th and 15th in November, Singclean launched new products Surgiclean Absorbable Hemostatic Particles and Singfiller Cross-linked Sodium Hyaluronate Gel. The first product launch show attracted more than 100 professional audiences including distributors and professors from Europe, Asia, Latin America, Africa and Middle East, etc.
Singclean also invited Mr. TAKASHI HASHIMOTO from Kewpie Corporation, who's an expert in the Hyaluronic Acid field to share industry trend.
After this launch show, 4 contracts signed with the clients from Serbia, Belgium, Slovakia, Mexico and more constructive business memos confirmed.
With the achievements and constructive processes made in MEDICA 2018, Singclean people forward a firm step to our goal : To be the leading manufacturer of Absorbable Biomaterial Medical Devices.
-
singclean | 2018-11-16Singclean Draws Major Attention at ESCRS 2025 with Advanced Viscoelastic Solution for Ophthalmic SurgeryCOPENHAGEN, DENMARK – Hangzhou Singclean Medical Products Co., Ltd. made a strong impression at the 45th ESCRS Congress (European Society of Cataract and Refractive Surgeons), held September 12–16, 2025, at the Bella Center in Copenhagen. Recognized globally for its high professional standards and influence in ophthalmology, the congress gathered leading industry manufacturers, surgeons, and specialists from around the world.
-
singclean | 2018-11-16Singderm Filler Achieves 92.7% Efficacy at 12 Months in Global Clinical Trial, Validated by Landmark Thailand MasterclassBangkok, Thailand – Singderm, a globally certified dermal filler brand, has demonstrated unprecedented clinical performance in its Thailand Masterclass led by renowned physician Dr. Worawat Nolah. Three top KOLs (Hack Anantaya, Chalidaorn PinNy, Thantaya Thuranuch) received multi-zone injections with zero complications, reinforcing Singderm’s 92.7% 12-month efficacy rate from a 100-subject clinical trial.
-
singclean | 2018-11-16Singclean to Showcase Innovative Medical Solutions at Key International Exhibitions in Bangkok and Copenhagen